We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Clinical feasibility of two-step streptavidin/<sup>111</sup>In-biotin scintigraphy in patients with suspected vertebral osteomyelitis.
- Authors
Lazzeri, Elena; Pauwels, Ernest K. J.; Erba, Paola A.; Volterrani, Duccio; Manca, Mario; Bodei, Lisa; Trippi, Donatella; Bottoni, Antonio; Cristofani, Renza; Consoli, Vincenzo; Palestro, Christopher J.; Mariani, Giuliano
- Abstract
Purpose. Streptavidin accumulates at sites of inflammation and infection as a result of increased capillary permeability. In addition to being utilised by bacteria for their own growth, biotin forms a stable, high-affinity non-covalent complex with avidin. The objective of this investigation was to determine the diagnostic performance of two-step streptavidin/111In-biotin imaging for evaluating patients with suspected vertebral osteo-myelitis. Methods. We evaluated 55 consecutive patients with suspected vertebral osteomyelitis (34 women and 21 men aged 27-86 years), within 2 weeks after the onset of clinical symptoms. Thirty-two of the patients underwent magnetic resonance imaging (MRI) and 24, computed tomography (CT). DTPA-conjugated biotin was radiolabelIed by incubating 500 μg of DTPA-biotin with 111 MBq of 111In-chloride. Two-step scintigraphy was performed by first infusing 3 mg streptavidin intra-venously, followed 4 h later by 111In-hiotin. Imaging was begun 60 min later. Results. Streptavidin/111In-biotin scintigraphy was positive in 32/34 patients with spinal infection (94.12% sensitivity). The study was negative in 19/21 patients without infection (95.24% specificity). The corresponding results for MRI and CT were 54.17% and 35.29% (sensitivity), and 75% and 57.14% (specificity), respectively. All statistical parameters of diagnostic performance (Youden's J index, kappa measure of agreement with correct classification, accuracy, sensitivity, specificity, positive likelihood and negative likelihood) were clearly better for streptavidin/111In-biotin scintigraphy than for either MRI or CT. Conclusion. Streptavidin/111In-biotin scintigraphy is highly sensitive and specific for detecting vertebral osteomyelitis in the first 2 weeks after the onset of clinical symptoms, and is potentially very useful for guiding clinical decisions on instituting appropriate therapy.
- Publication
European Journal of Nuclear Medicine & Molecular Imaging, 2004, Vol 31, Issue 11, p1505
- ISSN
1619-7070
- Publication type
Academic Journal
- DOI
10.1007/s00259-004-1581-2